SINGAPORE, May 21 (Bernama-BUSINESS WIRE) -- Trading Technologies International, Inc. (TT), a global provider of high-performance professional trading software, infrastructure and data solutions, today announced that connectivity to CoinFLEX, the world’s first physically delivered bitcoin futures exchange, is now available to eligible professional and retail traders outside the U.S. through the TT® trading platform.
With this new link to CoinFLEX, TT users who are eligible to trade on CoinFLEX now have access to the world’s first physically delivered stablecoin-to-stablecoin futures contract, offering Tether (USDT) against Circle’s USD Coin (USDC). These stablecoins are pegged to the U.S. Dollar and allow traders and investors to trade on global cryptocurrency markets without dealing with slow and expensive bank wires.
http://mrem.bernama.com/viewsm.php?idm=34592
Friday, May 24, 2019
Tuesday, May 21, 2019
NRI FT INDIA AND DIGITAL ASSET TO DELIVER DAML DRIVEN APPLICATIONS TO CAPITAL MARKETS
KOLKATA, India, May 21 (Bernama-BUSINESS WIRE) -- Nomura Research Institute Financial Technologies India Pvt. Ltd. (NRI FT India), a wholly-owned subsidiary of Nomura Research Institute (NRI) (TOKYO: 4307), has partnered with Digital Asset to create innovative capital markets applications using DAML, the open source smart contract language created by Digital Asset to synchronize business processes and make transaction workflow more transparent and efficient.
DAML is used to model business processes using smart contracts, capturing the rights and obligations associated with any asset class, business transaction or complex multi-party workflow to drive automation and efficiency. DAML is a core component of a number of Digital Asset projects and proofs of concept, including those with the ASX, HKEX and other market infrastructure providers.
Mr. Maulindu Chatterjee, Head of Global Delivery at NRI FT India said, “Our rich domain expertise in capital markets and years of experience delivering mission-critical solutions has helped us rapidly establish competencies with DAML, a technology we find is getting adopted by major markets in the APAC region such as ASX & HKEX.”
“Importantly,” Chatterjee added, “DAML has significantly enriched our capabilities as we build out complex enterprise workflows for a range of financial products. NRI FT India was able to develop multiple Proof of Concepts with DAML Smart Contracts within a short span of just five months. NRI FT India is looking forward to expanding the work we’re doing with Digital Asset in the Australian, Hong Kong and Japanese markets. Our collaboration with Digital Asset is a major strategic business opportunity for us.”
“We are delighted to partner with NRI FT India - its deep expertise and global delivery capability will help us scale our solutions and meet the rigorous needs of systemically consequential capital market infrastructures and financial institutions in APAC,” said Jon Rout, Business Development Director Asia Pacific for Digital Asset. We look forward to expanding the work we are doing with NRI FT India on significant client engagements and exploring new business opportunities together in the future.”
About DAML
DAML is an open source functional programming language designed specifically for use in multi-party business processes. DAML abstracts away the underlying complexities of blockchains and database technologies, allowing developers to focus on the logic of the applications they are building. For more information about DAML, please visit daml.com
About Digital Asset
Founded in 2014, Digital Asset is a leading provider of distributed ledger technology (DLT) solutions that solve real-world business challenges. The company combines deep industry expertise with advanced technologies, including DAML, an intuitive smart contract language, to help clients streamline multi-party business processes on distributed platforms. To learn more about Digital Asset, please visit https://www.digitalasset.com. To learn more about DAML, please visit https://www.daml.com.
About Nomura Research Institute Financial Technologies India Pvt. Ltd
Founded in 2001, Nomura Research Institute Financial Technologies India Pvt. Ltd. (NRI FT India) is a wholly-owned subsidiary of Nomura Research Institute (NRI). NRI FT India provides a range of reliable, scalable and adaptable IT Solutions to capital market entities around the world and has established the technical excellence and successful implementation track records in developed markets like Japan, Australia, USA, UK, Hong Kong, Singapore, as well as emerging markets like Thailand, Sri Lanka and Mongolia. To learn more about NRI FT India, please visit www.nrifintech.com.
About Nomura Research Institute (NRI)
Founded in 1965, NRI is a leading global provider of system solutions and consulting services, including management consulting, system integration, and IT management and solutions for financial, manufacturing, retail and service industries. Clients partner with NRI to expand businesses, design corporate structures and create new business strategies. NRI has about 13,000 employees in more than 50 offices globally including New York, London, Tokyo, Hong Kong, Singapore, and Australia. NRI reports annual sales above $4.2 billion. For more information, visit www.nri.com/en
http://mrem.bernama.com/viewsm.php?idm=34595
DAML is used to model business processes using smart contracts, capturing the rights and obligations associated with any asset class, business transaction or complex multi-party workflow to drive automation and efficiency. DAML is a core component of a number of Digital Asset projects and proofs of concept, including those with the ASX, HKEX and other market infrastructure providers.
Mr. Maulindu Chatterjee, Head of Global Delivery at NRI FT India said, “Our rich domain expertise in capital markets and years of experience delivering mission-critical solutions has helped us rapidly establish competencies with DAML, a technology we find is getting adopted by major markets in the APAC region such as ASX & HKEX.”
“Importantly,” Chatterjee added, “DAML has significantly enriched our capabilities as we build out complex enterprise workflows for a range of financial products. NRI FT India was able to develop multiple Proof of Concepts with DAML Smart Contracts within a short span of just five months. NRI FT India is looking forward to expanding the work we’re doing with Digital Asset in the Australian, Hong Kong and Japanese markets. Our collaboration with Digital Asset is a major strategic business opportunity for us.”
“We are delighted to partner with NRI FT India - its deep expertise and global delivery capability will help us scale our solutions and meet the rigorous needs of systemically consequential capital market infrastructures and financial institutions in APAC,” said Jon Rout, Business Development Director Asia Pacific for Digital Asset. We look forward to expanding the work we are doing with NRI FT India on significant client engagements and exploring new business opportunities together in the future.”
About DAML
DAML is an open source functional programming language designed specifically for use in multi-party business processes. DAML abstracts away the underlying complexities of blockchains and database technologies, allowing developers to focus on the logic of the applications they are building. For more information about DAML, please visit daml.com
About Digital Asset
Founded in 2014, Digital Asset is a leading provider of distributed ledger technology (DLT) solutions that solve real-world business challenges. The company combines deep industry expertise with advanced technologies, including DAML, an intuitive smart contract language, to help clients streamline multi-party business processes on distributed platforms. To learn more about Digital Asset, please visit https://www.digitalasset.com. To learn more about DAML, please visit https://www.daml.com.
About Nomura Research Institute Financial Technologies India Pvt. Ltd
Founded in 2001, Nomura Research Institute Financial Technologies India Pvt. Ltd. (NRI FT India) is a wholly-owned subsidiary of Nomura Research Institute (NRI). NRI FT India provides a range of reliable, scalable and adaptable IT Solutions to capital market entities around the world and has established the technical excellence and successful implementation track records in developed markets like Japan, Australia, USA, UK, Hong Kong, Singapore, as well as emerging markets like Thailand, Sri Lanka and Mongolia. To learn more about NRI FT India, please visit www.nrifintech.com.
About Nomura Research Institute (NRI)
Founded in 1965, NRI is a leading global provider of system solutions and consulting services, including management consulting, system integration, and IT management and solutions for financial, manufacturing, retail and service industries. Clients partner with NRI to expand businesses, design corporate structures and create new business strategies. NRI has about 13,000 employees in more than 50 offices globally including New York, London, Tokyo, Hong Kong, Singapore, and Australia. NRI reports annual sales above $4.2 billion. For more information, visit www.nri.com/en
http://mrem.bernama.com/viewsm.php?idm=34595
Thursday, May 16, 2019
Wednesday, May 15, 2019
AENEAS CAPITAL AND PYRINAS TARGET LAUNCH OF US$120M FUND TO DEVELOP CO-WORKING LABORATORY ECOSYSTEMS FOR LIFE SCIENCES START-UPS IN THE UNITED STATES
HONG KONG, May 16 (Bernama-BUSINESS WIRE) --
- Aeneas Capital and Pyrinas, both affiliated companies to Aptorum Group Ltd (Nasdaq: APM), is launching its flagship fund - Pyrinas US Healthcare Real Estate Fund 1 SP – to acquire and develop co-working space and incubator facilities for the life sciences sector in the United States;
- Opportunity to invest in one of the most vibrant real estate sectors in the U.S. that is currently not available in most of the Asia Pacific countries. A great geographical and asset class diversification of Asia Pacific real estate investment;
- Tap into the life sciences sector that generally has one of the highest barriers to entry amongst different industries;
- Experienced and unique advisory/management team in this specific sector with established operation track record.
Aeneas Capital Limited (“ACL”) and Pyrinas Real Estate Management Limited (“Pyrinas”), based in Hong Kong, is launching a US$120m innovative closed-ended property fund – Pyrinas US Healthcare Real Estate Fund 1 SP – with a geographical focus on selected cities across North America. Supported by the ecosystem of its affiliated company, Aptorum Group (Nasdaq: APM), the fund’s key investment objective is to acquire and redevelop real estate into shared laboratories and incubator facilities for life science sector start-ups, one of the most vibrant sectors in North America. The fund will focus its investments in primarily four North America mandated cities (namely Cambridge, Boston, Houston, and San Francisco in the United States and Toronto in Canada).
PAYVISION CELEBRATES ITS 1ST ANNIVERSARY WITH ING WITH OVER 50% GROWTH AND A BRAND-NEW VISUAL AND SONIC IDENTITY
AMSTERDAM, The Netherlands, May 15 (Bernama-GLOBE NEWSWIRE) --Payvision, a global payments fintech player celebrates its one-year partnership with ING, one of the largest European banks, with a brand-new visual and sonic identity, marking the company’s shift into a new era. Payvision had an excellent year in 2018, fueled by its strategic partnership with ING, a complete rebranding process, and more than a 50% increase in transaction volume.
During the first year, the ING-Payvision partnership brought forward an exclusive blend of payments and banking products to the industry, positioning the two as a financial services powerhouse. Besides serving merchants across the globe with a data-driven, omnichannel payments platform, the combined proposition also integrates Internet of Things capabilities from both companies, such as FINN, into a wider fintech ecosystem. This empowers Payvision to accommodate any payment method a merchant could ask for; from traditional cards, to Apple Pay, soon to be introduced by ING in the Netherlands, as well as invisible payment capabilities in the future. In 2018, the strategic focus was placed on serving mid-sized merchants in Belgium and the Netherlands, and large corporates with a global reach. During 2019, this is planned to be extended to all SME customers of ING.
http://mrem.bernama.com/viewsm.php?idm=34555
During the first year, the ING-Payvision partnership brought forward an exclusive blend of payments and banking products to the industry, positioning the two as a financial services powerhouse. Besides serving merchants across the globe with a data-driven, omnichannel payments platform, the combined proposition also integrates Internet of Things capabilities from both companies, such as FINN, into a wider fintech ecosystem. This empowers Payvision to accommodate any payment method a merchant could ask for; from traditional cards, to Apple Pay, soon to be introduced by ING in the Netherlands, as well as invisible payment capabilities in the future. In 2018, the strategic focus was placed on serving mid-sized merchants in Belgium and the Netherlands, and large corporates with a global reach. During 2019, this is planned to be extended to all SME customers of ING.
http://mrem.bernama.com/viewsm.php?idm=34555
Monday, May 13, 2019
KOREAN DIGITAL MARKETING GROUP CREATIP REBRANDS SUCCESSFULLY
SEOUL, South Korea, May 13 (Bernama-BUSINESS WIRE) -- Creatip (CEO: Daniel Kong), a global digital marketing group, rebranded itself to improve the efficiency of communication with potential global customers.
Founded in 2008, the Korean digital marketing group has provided global customers with marketing performances and full social media marketing services. The company is rapidly growing recently, expanding its area into digital video making and marketing consulting.
http://mrem.bernama.com/viewsm.php?idm=34537
Founded in 2008, the Korean digital marketing group has provided global customers with marketing performances and full social media marketing services. The company is rapidly growing recently, expanding its area into digital video making and marketing consulting.
http://mrem.bernama.com/viewsm.php?idm=34537
Takeda accelerates deleveraging via two divestitures
KUALA LUMPUR, May 9 (Bernama) -- Takeda Pharmaceutical Company Limited (Takeda) has entered into agreements to divest its Xiidra® (lifitegrast ophthalmic solution) 5% product (Xiidra®) to Novartis and its TachoSil® Fibrin Sealant Patch (TachoSil®) to Ethicon.
The two divestitures are part of Takeda’s strategy to focus on business core areas to its long-term growth and facilitate rapid deleveraging following its acquisition of Shire.
Takeda will receive US$3.4 billion upfront in cash and up to an additional US$1.9 billion in potential milestone payments from Novartis, and approximately US$400 million upfront in cash from Ethicon. (US$1=RM4.15)
It will use the proceeds to reduce its debt and accelerate deleveraging towards its target of 2.0x net debt/adjusted EBITDA in the medium term.
Takeda president and chief executive officer, Christophe Weber said: “We are working to strategically simplify and optimise our portfolio, while also rapidly deleveraging and continuing to invest in our growth drivers as a global, values-based, R&D-driven biopharmaceutical leader.”
Takeda will focus on its key business areas – gastroenterology, rare diseases, plasma-derived therapies, oncology and neuroscience.
This focus enables the pharmaceutical company to continue to deliver highly-innovative medicines and transformative care to patients worldwide, creating long-term value for its shareholders.
Both agreements are expected to close in the second half this year, subject to the satisfaction of customary closing conditions, receipt of required regulatory clearances and, where applicable, satisfaction of local works council requirements.
More details at https://www.takeda.com
-- BERNAMA
The two divestitures are part of Takeda’s strategy to focus on business core areas to its long-term growth and facilitate rapid deleveraging following its acquisition of Shire.
Takeda will receive US$3.4 billion upfront in cash and up to an additional US$1.9 billion in potential milestone payments from Novartis, and approximately US$400 million upfront in cash from Ethicon. (US$1=RM4.15)
It will use the proceeds to reduce its debt and accelerate deleveraging towards its target of 2.0x net debt/adjusted EBITDA in the medium term.
Takeda president and chief executive officer, Christophe Weber said: “We are working to strategically simplify and optimise our portfolio, while also rapidly deleveraging and continuing to invest in our growth drivers as a global, values-based, R&D-driven biopharmaceutical leader.”
Takeda will focus on its key business areas – gastroenterology, rare diseases, plasma-derived therapies, oncology and neuroscience.
This focus enables the pharmaceutical company to continue to deliver highly-innovative medicines and transformative care to patients worldwide, creating long-term value for its shareholders.
Both agreements are expected to close in the second half this year, subject to the satisfaction of customary closing conditions, receipt of required regulatory clearances and, where applicable, satisfaction of local works council requirements.
More details at https://www.takeda.com
-- BERNAMA
Subscribe to:
Posts (Atom)